Acadia Healthcare Company (ACHC) EBIT (2010 - 2026)

Acadia Healthcare Company (ACHC) has 17 years of EBIT data on file, last reported at -$120.1 million in Q1 2026.

• EBIT for Q1 2026 came in at -$120.1 million, down 707.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 4590.71% YoY), and the FY2025 annual result was -$223.8 million, down 126.32% from the prior year.
• EBIT improved to -$120.1 million in Q1 2026 per ACHC's latest filing, from -$1.2 billion in the prior quarter.
• Over five years, EBIT peaked at $78.6 million in Q2 2024 and troughed at -$1.2 billion in Q4 2025.
• A 5-year average of -$121.0 million and a median of -$13.6 million in 2024 frame the typical range for EBIT.
• The sharpest annual moves came in 2023 and 2024: EBIT sank 3978.96% in 2023, then soared 15070.27% in 2024.
• A 5-year view of EBIT shows it stood at -$186.9 million in 2022, then retreated by 22.85% to -$229.6 million in 2023, then jumped by 65.21% to -$79.9 million in 2024, then plunged by 1402.45% to -$1.2 billion in 2025, then soared by 89.99% to -$120.1 million in 2026.
• Business Quant data shows ACHC's EBIT at -$120.1 million in Q1 2026, -$1.2 billion in Q4 2025, and $9.6 million in Q3 2025.